JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FOSTER, R. H. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FOSTER, R. H. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 65, Issue 1, 1-17, 1939
Copyright © 1939 by American Society for Pharmacology and Experimental Therapeutics


STANDARDIZATION OF SAFETY MARGIN

R. H. K. FOSTER 1

1 From the Research Laboratories, Scientific Department, Hoffmann-La Roche, Inc., Nutley, N. J.

1. An improved standard for measuring the safety margin of drugs has been proposed. It is based on the determination of the dose-effect relationship, using suitable functions of dose and per cent effect. Statistical formulae necessary for making all calculations have been given.

2. Safety margin in the present concept is termed "Standard Safety Margin" and is defined as the zone between the surely effective dose (ED99) and the lowest lethal dose (LD1). It is expressed as a per cent of the ED99.

3. The "standard safety margin," calculated by the proposed method, lays increased emphasis on the actual zone of safety between the dose almost certain to be therapeutically effective and the dose likely to cause an occasional death.

4. Calculation of "standard safety margin" is made with the formula:

[See equation in the PDF file]

or by its logarithmic equivalent given in the text.

5. For allylisopropyl barbituric acid administered subcutaneously in the form of the sodium salt the ND50 in mice is 45 micrograms per gram body weight, and the LD50 is 237 micrograms per gram. The median therapeutic index is 5.24 and the standard safety margin 105 per cent.

6. For phenylethyl barbituric acid administered subcutaneously in the form of the sodium salt the ND50 in mice is 101 micrograms per gram, body weight, and the LD50 is 265 micrograms per gram. The median therapeutic index is 2.62 and the standard safety margin 34 per cent.

Submitted on March 17, 1938







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1939 by the American Society for Pharmacology and Experimental Therapeutics.